(NaturalHealth365)  Millions of Americans are taking Ozempic, Wegovy, and similar weight-loss drugs and watching the number on the scale drop.  What most people are not watching is what is happening to their bones.  New research presented at the 2026 annual meeting of the American Academy of Orthopaedic Surgeons has identified a troubling pattern in long-term GLP-1 users.  To make matters worse, most prescribing physicians are not discussing the findings.

Researchers analyzed five years of medical records from more than 146,000 adults with obesity and type 2 diabetes.  GLP-1 users developed osteoporosis at a 29% higher relative risk than nonusers (4.1% vs 3.2%).

The risk of osteomalacia, a condition involving bone softening, more than doubled.  A separate February 2026 study in the Journal of Clinical Endocrinology & Metabolism found that older adults on GLP-1 drugs had an 11% higher risk of fragility fractures.  That study compared them against those on other diabetes medications, and all differences were statistically significant.

The five-year data that drug commercials will never mention

Randomized controlled trial data adds further weight to the concern.  A phase 2 randomized clinical trial found that 52 weeks of once-weekly semaglutide reduced hip bone mineral density by 2.6% compared to placebo.  Lumbar spine density dropped by 2.1%.  Bone resorption markers increased throughout the trial, while bone formation markers did not compensate.

The body was breaking down bone faster than rebuilding could keep pace, with no recovery signal while the drug remained active.

Roughly 12% of Americans are currently taking a GLP-1 medication.  As many as 35% report interest in using one.  That means tens of millions of people may be on a trajectory toward accelerated bone loss.  Most have received no screening, no guidance on supplementation, and no discussion of how rapid, pharmaceutical-driven weight loss affects the skeleton over time.

Why appetite suppression quietly depletes the skeleton

The mechanism behind bone risk is not mysterious.  When appetite drops dramatically, food intake falls, and with that drop goes the calcium, vitamin D, magnesium, and protein that bone tissue depends on to maintain density and repair cellular damage.

Bone is a dynamic system that continuously breaks down old tissue and rebuilds new tissue.  That process requires a steady supply of specific nutrients to stay in balance.

When that nutrient supply is cut by appetite suppression, breakdown outpaces rebuilding.  Weight loss compounds the problem because bones respond to mechanical load.  Lighter bodies place less stress on the skeleton, and the skeleton responds by reducing density.

Every pound lost reduces the stimulus that tells bone cells to maintain mass.

Steps every GLP-1 user should take now

Make calcium, vitamin D, and protein non-negotiable daily priorities.  Because appetite suppression reduces food intake, GLP-1 users face a real risk of falling below the nutrient thresholds bone maintenance requires.  Calcium intake should reach 1,000 to 1,200 milligrams daily.  Vitamin D blood levels should sit between 40 and 60 ng/mL.

Most people on standard amounts do not reach that target without testing and adjustment.  Aim for protein intake of 1.2 to 1.6 grams per kilogram of body weight daily.  That level supports both muscle preservation and the collagen matrix that gives bone structural integrity.

Treat resistance exercise as a medical intervention, not an optional habit.  Mechanical load is one of the most powerful signals the body uses to maintain bone density.  Weight-bearing and resistance training signal bone cells to remain active and rebuild bone.  Research consistently confirms that resistance exercise preserves bone mineral density during weight loss.  Even two to three sessions per week of bodyweight exercises or light free weights provide significant skeletal protection.

Support bone metabolism through targeted supplementation beyond calcium alone.  Magnesium is required for calcium absorption and is frequently depleted alongside vitamin D.  Vitamin K2 directs calcium into bone tissue rather than arterial walls, a distinction relevant to both bone health and cardiovascular protection.

In addition, collagen peptide supplementation has shown positive effects on bone mineral density in clinical trials, and the connective tissue framework that holds bone structure together also depends on adequate collagen.

The full picture matters as much as the number on the scale

Five years of data have confirmed what the mechanism always suggested.  Drugs that suppress appetite and drive rapid weight loss also reduce the nutritional inputs and mechanical stimuli that bone tissue needs to stay strong.

Jonathan Landsman’s Whole Body Detox Summit addresses how pharmaceutical interventions affect nutritional status and long-term cellular health.  For anyone on a GLP-1 medication, understanding how to protect the body during that process is essential.

Click here to own the Whole Body Detox Summit.

Sources for this article include:

Submissions.mirasmart.com
Aaos-annualmeeting-presskit.org
Drugs.com